PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study

• click to rate

  Posted by Two Blokes Jul 9 - Filed in Stock - 6 views
  
  Shares of ProKidney jump 515% after its kidney cell therapy shows strong efficacy in a Phase II diabetes-related CKD study.